Default



Default

Home | Contact Us | Site Index | Search UW:

Gabriel S. Aldea, M.D.

 Gabriel Aldea photo

Patient Services:

Surgical Specialties Center at UWMC, Tuesdays at 1:00-5:00 pm

Phone: 206-598-8300

Physician Referral: (206) 598-3636 or 221-3288 or toll-free: 1 (866) UW HEART (894-3278)

Academic Office:

Phone: (206) 543-3093

E-mail:
aldea@u.washington.edu

Fax: (206) 543-0325

Address:
Gabriel S. Aldea, M.D.
University of Washington
Department of Surgery
Box 356310
Seattle, WA 98195-6310

Professor
Section Chief, Adult Cardiac Surgery

Faculty Appointments:

University of Washington, Professor, 2002 - present.

University of Washington, Associate Professor, 1998 - 2002.

Boston University School of Medicine, Associate Professor, 1996-98.

Boston University School of Medicine, Assistant Professor, 1990-96.

Education:

Fellowships: Cardiovascular Research Institute, University of California San Francisco, 1986-88.

New York Hospital - Cornell Medical Center and Memorial Sloan-Kettering Hospital, Cardiothoracic Surgery, 1988-90.

Residency: New York Hospital - Cornell Medical Center 1981-86.

M.D. Degree: Columbia University, 1977.

Board Certified: Medical Examiners, 1982. General Surgery, 1987; recertified, 1996. Thoracic Surgery, 1991; recertified, 2000.

Clinical Interests:

  • Arterial revascularization
  • Valvular replacement/repair
  • Thoracic aortic surgery (root, ascending, arch, descending thoracic aorta)
  • Thoracic endovascular aortic stent surgery (TEVAR)
  • Maze atrial fibrillation surgery
  • Less invasive surgery
  • Biocompatable cardio-pulmonary bypass

Research Interests:

  • Coronary sinus retroperfusion
  • Limiting inflammatory response to cardiopulmonary bypass
  • Neurological/ neuropsychological responses to cardiopulmonary bypass
  • Biocompatable cardiopulmonary bypass
  • Alternatives to heparin anticoagulation
  • Blood conservation
  • Quality assessment and outcomes in cardiac surgery (National-STS, Washington State’s COAP Databases)

download Annual Research Report

Selected Publications:

Koster A, Dyke CM, Aldea GS, Smedira NG, McCarthy HL, Aronson S, Hetzer R, Avery E, Speiss B, and Lincoff M. Bivalirudin during cardiopulmonary bypass in patients with previous or acute heparin-induced thrombocytopenia and heparin antibodies: results of the CHOOSE-On Trial. Ann Thorac Surg, 2007; 83: 572-7.

Goss JR, Maynard C, Aldea GS, et al. Effects of a statewide physician-led quality improvement program on the quality of cardiac care. American Heart Journal, 2006: 151: 1040-9.

Eisses MJ, Velan T, Aldea GS, Chandler WL. Strategies to reduce hemostatic activation during cardiopulmonary bypass. Thromb Res, 2006(6);117:689-703.

Eisses MJ, Aldea GS, Chandler WL. Reducing Hemostatic Activation during CPB: a Combined Approach. Anesth & Analg, 2004; 98(5):1208-16.

Aldea GS, Soltow LO, Chandler WL, Triggs CM, Vocelka CR, Crockett GI, Shin YT, Curtis WE, Verrier ED. Limitation of thrombin generation, platelet activation and inflammation by elimination of cardiotomy suction in patients undergoing coronary artery bypass grafting treated with heparin-bonded circuits. J Thorac Cardiov Surg, 2002; 123(4):742-755.

 

reviewed 2/07